Select Publications
Journal articles
, 2025, 'Predicting immune protection against outcomes of infectious disease from population-level effectiveness data with application to COVID-19', Vaccine, 55, pp. 126987, http://dx.doi.org/10.1016/j.vaccine.2025.126987
, 2025, 'Estimating the cost-effectiveness of maternal respiratory syncytial virus (RSV) vaccination in Australia: A dynamic and economic modelling analysis', Vaccine, 46, http://dx.doi.org/10.1016/j.vaccine.2024.126651
, 2024, 'Modelling the epidemiological impact of maternal respiratory syncytial virus (RSV) vaccination in Australia', Vaccine, 42, http://dx.doi.org/10.1016/j.vaccine.2024.126418
, 2024, 'Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic', Ebiomedicine, 110, http://dx.doi.org/10.1016/j.ebiom.2024.105415
, 2024, 'Review of mathematical models of Neisseria gonorrhoeae vaccine impact: Implications for vaccine development', Vaccine, 42, pp. S70 - S81, http://dx.doi.org/10.1016/j.vaccine.2024.03.068
, 2024, 'Opportunities to strengthen respiratory virus surveillance systems in Australia: lessons learned from the COVID-19 response', Communicable Diseases Intelligence 2018, 48, http://dx.doi.org/10.33321/cdi.2024.48.47
, 2024, 'Estimating the impact of test–trace–isolate–quarantine systems on SARS-CoV-2 transmission in Australia', Epidemics, 47, http://dx.doi.org/10.1016/j.epidem.2024.100764
, 2024, 'Assessing the effects of SARS-CoV-2 vaccination on the risk of household transmission during delta variant circulation: a population-based data linkage cohort study', Lancet Regional Health Western Pacific, 42, http://dx.doi.org/10.1016/j.lanwpc.2023.100930
, 2024, 'Trends in intravenous immunoglobulin use in New South Wales, Australia', Internal Medicine Journal, 54, pp. 149 - 156, http://dx.doi.org/10.1111/imj.16175
, 2024, 'Unlocking the value of Shingrix: how vaccination empowers older adults', MICROBIOLOGY AUSTRALIA, 45, pp. 184 - 187, http://dx.doi.org/10.1071/MA24051
, 2023, 'Real-time analysis of hospital length of stay in a mixed SARS-CoV-2 Omicron and Delta epidemic in New South Wales, Australia', BMC Infectious Diseases, 23, http://dx.doi.org/10.1186/s12879-022-07971-6
, 2023, 'The potential impact of a vaccine on Neisseria gonorrhoeae prevalence among heterosexuals living in a high prevalence setting', Vaccine, 41, pp. 5553 - 5561, http://dx.doi.org/10.1016/j.vaccine.2023.07.048
, 2023, 'COVID-19 vaccine coverage targets to inform reopening plans in a low incidence setting', Proceedings of the Royal Society B Biological Sciences, 290, http://dx.doi.org/10.1098/rspb.2023.1437
, 2023, 'The changing epidemiology of Neisseria gonorrhoeae genogroups and antimicrobial resistance in Queensland, Australia, 2010-15: A case series analysis of unique Neisseria gonorrhoeae isolates', Sexual Health, 20, pp. 296 - 302, http://dx.doi.org/10.1071/SH22118
, 2023, 'Estimating the excess burden of pertussis disease in Australia within the first year of life, that might have been prevented through timely vaccination', International journal of epidemiology, 52, pp. 250 - 259, http://dx.doi.org/10.1093/ije/dyac175
, 2022, 'Modelled estimates of hospitalisations attributable to respiratory syncytial virus and influenza in Australia, 2009–2017', Influenza and Other Respiratory Viruses, 16, pp. 1082 - 1090, http://dx.doi.org/10.1111/irv.13003
, 2022, 'Global variation in early epidemic growth rates and reproduction number of seasonal influenza', International Journal of Infectious Diseases, 122, pp. 382 - 388, http://dx.doi.org/10.1016/j.ijid.2022.06.022
, 2022, 'Impact of a national immunisation program on herpes zoster incidence in Australia', Journal of Infection, 84, pp. 537 - 541, http://dx.doi.org/10.1016/j.jinf.2022.01.011
, 2022, 'A Gonococcal Vaccine Has the Potential to Rapidly Reduce the Incidence of Neisseria gonorrhoeae Infection among Urban Men Who Have Sex with Men', Journal of Infectious Diseases, 225, pp. 983 - 993, http://dx.doi.org/10.1093/infdis/jiab581
, 2022, 'Impact of a structured older persons health assessment on herpes zoster vaccine uptake in Australian primary care', Preventive Medicine, 155, http://dx.doi.org/10.1016/j.ypmed.2021.106946
, 2021, 'Modelling response strategies for controlling gonorrhoea outbreaks in men who have sex with men in Australia', Plos Computational Biology, 17, pp. e1009385, http://dx.doi.org/10.1371/journal.pcbi.1009385
, 2021, '472Long-term effectiveness of 3-dose primary course and 4-year booster dose of pertussis vaccine in Australia', International Journal of Epidemiology, 50, http://dx.doi.org/10.1093/ije/dyab168.321
, 2021, '473Preventable pertussis burden in Australia within the first year of life by improving vaccination timeliness', International Journal of Epidemiology, 50, http://dx.doi.org/10.1093/ije/dyab168.322
, 2021, 'Understanding COVID-19 dynamics and the effects of interventions in the Philippines: A mathematical modelling study', Lancet Regional Health Western Pacific, 14, pp. 100211, http://dx.doi.org/10.1016/j.lanwpc.2021.100211
, 2021, 'Estimating pertussis incidence in general practice using a large Australian primary care database', Vaccine, 39, pp. 4153 - 4159, http://dx.doi.org/10.1016/j.vaccine.2021.05.079
, 2021, 'Effectiveness of the live-attenuated herpes zoster vaccine 2 years after its introduction in Australia', Vaccine, 39, pp. 1493 - 1498, http://dx.doi.org/10.1016/j.vaccine.2021.01.067
, 2021, 'On realized serial and generation intervals given control measures: The COVID-19 pandemic case', Plos Computational Biology, 17, pp. e1008892, http://dx.doi.org/10.1371/journal.pcbi.1008892
, 2021, 'Global production capacity of seasonal and pandemic influenza vaccines in 2019', Vaccine, 39, pp. 512 - 520, http://dx.doi.org/10.1016/j.vaccine.2020.12.018
, 2020, 'Coronavirus disease model to inform transmission reducing measures and health system preparedness, Australia', Emerging Infectious Diseases, 26, pp. 2844 - 2853, http://dx.doi.org/10.3201/EID2612.202530
, 2020, 'Delay-adjusted age- and sex-specific case fatality rates for COVID-19 in South Korea: Evolution in the estimated risk of mortality throughout the epidemic', International Journal of Infectious Diseases, 101, pp. 306 - 311, http://dx.doi.org/10.1016/j.ijid.2020.09.1478
, 2020, 'Early analysis of the australian covid-19 epidemic', Elife, 9, pp. 1 - 14, http://dx.doi.org/10.7554/ELIFE.58785
, 2020, 'Emergence of pertactin-deficient pertussis strains in Australia can be explained by models of vaccine escape', Epidemics, 31, pp. 100388, http://dx.doi.org/10.1016/j.epidem.2020.100388
, 2020, 'Herpes zoster vaccine coverage in Australia before and after introduction of a national vaccination program', Vaccine, 38, pp. 3646 - 3652, http://dx.doi.org/10.1016/j.vaccine.2020.03.036
, 2020, 'High healthcare resource utilisation due to pertussis in Australian adults aged 65 years and over', Vaccine, 38, pp. 3553 - 3559, http://dx.doi.org/10.1016/j.vaccine.2020.03.021
, 2020, 'Burden of congenital rubella syndrome (Crs) in Bangladesh: Systematic review of existing literature and transmission modelling of seroprevalence studies', Infectious Disorders Drug Targets, 20, pp. 284 - 290, http://dx.doi.org/10.2174/1871526518666181004092758
, 2020, 'Trends in chronic hepatitis B prevalence in Australian women by country of birth, 2000 to 2016', Journal of Viral Hepatitis, 27, pp. 74 - 80, http://dx.doi.org/10.1111/jvh.13202
, 2019, 'Reply to letter: Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia', Vaccine, 37, pp. 7534, http://dx.doi.org/10.1016/j.vaccine.2019.09.108
, 2019, 'Modelling the in-host dynamics of Neisseria gonorrhoeae infection', Pathogens and Disease, 77, http://dx.doi.org/10.1093/femspd/ftz008
, 2019, 'Estimating seasonal variation in Australian pertussis notifications from 1991 to 2016: Evidence of spring to summer peaks', Epidemiology and Infection, 147, pp. 1 - 8, http://dx.doi.org/10.1017/S0950268818003680
, 2019, 'Modelling the decline and future of hepatitis A transmission in Australia', Journal of Viral Hepatitis, 26, pp. 199 - 207, http://dx.doi.org/10.1111/jvh.13018
, 2019, 'Pneumonia hospitalisation and case-fatality rates in older australians with and without risk factors for pneumococcal disease: Implications for vaccine policy', Epidemiology and Infection, 147, http://dx.doi.org/10.1017/S0950268818003473
, 2019, 'PIN56 EXCESS HEALTHCARE RESOURCE UTILISATION ASSOCIATED WITH PERTUSSIS INFECTION IN OLDER ADULTS', Value in Health, 22, pp. S649 - S649, http://dx.doi.org/10.1016/j.jval.2019.09.1298
, 2018, 'Treatment for pharyngeal gonorrhoea under threat', Lancet Infectious Diseases, 18, pp. 1175 - 1177, http://dx.doi.org/10.1016/S1473-3099(18)30610-8
, 2018, 'Retrospective cost-effectiveness of the 23-valent pneumococcal polysaccharide vaccination program in Australia', Vaccine, 36, pp. 6307 - 6313, http://dx.doi.org/10.1016/j.vaccine.2018.08.084
, 2018, 'Within-season influenza vaccine waning suggests potential net benefits to delayed vaccination in older adults in the United States', Vaccine, 36, pp. 5910 - 5915, http://dx.doi.org/10.1016/j.vaccine.2018.08.007
, 2018, 'Australian rubella serosurvey 2012–2013: On track for elimination?', Vaccine, 36, pp. 2794 - 2798, http://dx.doi.org/10.1016/j.vaccine.2018.03.086
, 2018, 'Eradicating hepatitis C from the New South Wales prison system', Medical Journal of Australia, 208, pp. 276 - 2e1, http://dx.doi.org/10.5694/mja17.01077
, 2018, 'Estimates of global seasonal influenza-associated respiratory mortality: a modelling study', Lancet, 391, pp. 1285 - 1300, http://dx.doi.org/10.1016/S0140-6736(17)33293-2
, 2018, 'The role of timeliness in the cost-effectiveness of older adult vaccination: A case study of pneumococcal conjugate vaccine in Australia', Vaccine, http://dx.doi.org/10.1016/j.vaccine.2018.01.052
, 2018, 'Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: A review of the current status of the clinical development pipeline', Vaccine, pp. 1 - 8, http://dx.doi.org/10.1016/j.vaccine.2018.11.004